TerSera Therapeutics Completes Divestiture of Infusion Specialty Therapies Business to ESTEVE
DEERFIELD, Illinois & BARCELONA, Spain — March 11, 2026 The global pharmaceutical industry marked an important strategic development as...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
DEERFIELD, Illinois & BARCELONA, Spain — March 11, 2026 The global pharmaceutical industry marked an important strategic development as...
September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...
